文献速递儿童血液肿瘤与免疫儿童感染

儿童急性淋巴细胞白血病合并热带念珠菌血症14例临床分析

[Clinical analysis of 14 cases with childhood acute lymphoblastic leukemia complicated with tropical candidemia].
PubMed 文献 · Zhonghua Er Ke Za Zhi · 2020-01-01

该研究回顾性分析6家医院14例ALL合并热带念珠菌血症患儿,发现均有发热和中性粒细胞缺乏,10例进展为休克,死亡7例。C反应蛋白>50 mg/L比例显著高于其他侵袭性真菌病患儿,血培养均见热带念珠菌,多数对氟胞嘧啶和两性霉素B敏感。ALL未缓解、中性粒细胞缺乏>10天等为危险因素,推荐两性霉素B或棘白菌素联合氟胞嘧啶治疗耐唑类菌株。

要点

  • ALL合并热带念珠菌血症病死率高,14例中死亡7例
  • C反应蛋白>50 mg/L比例显著高于其他侵袭性真菌病患儿
  • 耐唑类热带念珠菌推荐两性霉素B或棘白菌素联合氟胞嘧啶治疗

核心结论

  • 儿童ALL合并热带念珠菌血症耐药率及病死率高,针对耐唑类热带念珠菌推荐两性霉素B脂质体或棘白菌素(卡泊芬净)联合氟胞嘧啶治疗以降低治疗相关死亡风险。

研究设计与样本

  • 回顾性分析2015年1月至2018年12月6家医院诊断的14例ALL合并CTBI患儿的一般资料、临床表现、辅助检查、治疗及转归。
  • 收集同期入院的无IFD的ALL患儿28例及其他IFD患儿9例作为对照组。
  • 采用Logistic回归分析探讨CTBI发生的危险因素。

主要发现

  • 14例患儿均有发热,9例有消化系统症状(3例粪培养有真菌),7例有呼吸系统症状(1例痰培养为真菌),2例有中枢神经症状,10例发生休克。
  • 14例均有中性粒细胞缺乏,持续时间1~53 d;C反应蛋白>50 mg/L比例为8/14,显著高于其他IFD病例的1/9(P<0.05)。
  • (1,3)-β-D-葡聚糖、半乳甘露聚糖检测及肺部影像学无特异性。
  • 14例血培养均见热带念珠菌,13例完善药敏,均对氟胞嘧啶、两性霉素B敏感,4例对氟康唑、伏立康唑、伊曲康唑敏感。
  • 14例中1例放弃治疗后失访,1例抗真菌治疗前死亡,余12例予抗真菌治疗;14例中死亡7例。

关键数值与推荐

  • ALL合并CTBI组(14例)与ALL未发生IFD组(28例)在ALL未缓解(χ²=37.847,P<0.01)、住院时间>15 d(χ²=8.351,P=0.004)、中性粒细胞缺乏(χ²=14.280,P<0.01)、中性粒细胞缺乏时间>10 d(χ²=10.254,P=0.001)、应用广谱抗菌药物(χ²=13.888,P<0.01)、皮肤黏膜破损(χ²=5.923,P=0.015)方面差异有统计学意义。
  • 针对耐唑类热带念珠菌,推荐使用两性霉素B或棘白菌素+氟胞嘧啶联合治疗。

临床怎么用

  • ALL患儿出现发热伴中性粒细胞缺乏>10天、住院时间>15天、应用广谱抗菌药物或皮肤黏膜破损时,应警惕CTBI可能。
  • C反应蛋白>50 mg/L有助于提示CTBI,而(1,3)-β-D-葡聚糖、半乳甘露聚糖及肺部影像学无特异性,需依赖血培养确诊。
  • 药敏提示对氟胞嘧啶和两性霉素B敏感,耐唑类菌株可选用两性霉素B或棘白菌素联合氟胞嘧啶治疗。

局限性

  • 回顾性研究,样本量较小(14例CTBI患儿),来自6家医院。
  • 1例放弃治疗后失访,可能影响转归分析。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Objective: To investigate the clinical feature, diagnosis, treatment and prognosis of childhood acute lymphoblastic leukemia (ALL) complicated with candida tropicalis bloodstream infection (CTBI), so as to improve the understanding of this disease. Methods: The general information, clinical manifestation, auxiliary examination, treatment and outcome of 14 childhood ALL who were diagnosed with tropical candidemia between January 2015 and December 2018 in 6 hospitals were analyzed retrospectively. Clinical data of non invasive fungal disease (IFD) ALL (28 cases) and other IFD children (9 cases) admitted in the same period were collected as control group. Logistic regression model was used to analyze the risk factor of CTBI. Results: Among 14 cases, there were 7 males and 7 females, with the age ranged from 17 months to 13 years. All the cases had fever, 9 cases had digestive system symptoms and stool fungal culture were positive in 3 of them; 7 cases had respiratory system symptoms and sputum fungal culture was positive in 1 of them; 2 cases had central nervous system symptoms and 10 cases progressed into septic shock. All 14 cases had neutropenia and the neutropenia duration was 1 to 53 days. Among 14 cases, the C-reactive protein was>50 mg/L in 8 cases, in which the proportion was significantly higher than that in other invasive fungal disease(IFD) (8/14 vs. 1/9, P<0.05), meanwhile the 1, 3-β-D-glucan detection, galactomannan detection and pulmonary imaging were not remarkable in all 14 cases. The blood culture results of 14 cases were all candida tropicalis, among which 13 cases finished drug susceptibility tests, the isolates of all cases were sensitive to flucytosine and amphotericin B, and the isolates of 4 cases were sensitive to fluconazole, voriconazole and itraconazole. Among 14 cases, 1 case lost to follow-up after giving up treatment, 1 case died before antifungal therapy and the remaining 12 cases received antifungal therapy; 7 of the 14 cases died. Univariate analysis showed that between ALL with CTBI group (14 cases) and ALL without invasive fungal disease (IFD) group (28 cases), the differences in variables such as ALL not in remission (χ²=37.847, P<0.01), length of hospital stay>15 days (χ2=8.351, P=0.004), neutropenia (χ²=14.280, P<0.01), neutropenia duration>10 days (χ²=10.254, P=0.001), use of broad-spectrum antibiotics (χ²=13.888, P<0.01), skin and mucous membrane damage (χ²= 5.923, P=0.015) were statistically significant. Conclusions: In childhood ALL complicated with tropical candidemia, the drug resistance rate and mortality rate were high. For azole-resistant tropical candida, amphotericin B liposome or echinocandins(caspofungin) -fluorocytosine combined therapy was recommended to reduce treatment-related deaths. 目的: 探讨儿童急性淋巴细胞白血病(ALL)合并热带念珠菌血症(CTBI)的临床特征、诊疗与预后,提高对该病的认识。 方法: 回顾性分析2015年1月至2018年12月在6家医院诊断的14例ALL合并CTBI患儿的一般资料、临床表现、辅助检查、治疗及转归情况。收集同期入院的无侵袭性真菌病(IFD)的ALL患儿(28例)及其他IFD患儿(9例)的临床资料作为对照组。采用Logistic回归分析探讨CTBI发生的危险因素。 结果: 14例患儿中男7例、女7例,年龄1岁5月龄~13岁。14例均有发热,9例有消化系统症状,3例粪培养有真菌;7例有呼吸系统症状,1例痰培养为真菌;2例有中枢神经症状;10例发生休克。14例患儿均有中性粒细胞缺乏,中性粒细胞缺乏持续时间1~53 d。C反应蛋白>50 mg/L的比例明显高于其他IFD病例(8/14比1/9,P<0.05),(1, 3)-β-D-葡聚糖、半乳甘露聚糖检测及肺部影像学无特异性。14例患儿血培养均可见热带念珠菌,13例完善药敏,均对氟胞嘧啶、两性霉素B敏感,4例对氟康唑、伏立康唑、伊曲康唑敏感。14例患儿中,1例放弃治疗后失访,1例在抗真菌治疗前死亡,余12例予抗真菌治疗;14例患儿中死亡7例。ALL合并CTBI组(14例)与ALL未发生IFD组(28例)在ALL未缓解(χ²=37.847,P<0.01)、住院时间>15 d(χ²=8.351,P=0.004)、中性粒细胞缺乏(χ²=14.280,P<0.01)、中性粒细胞缺乏时间>10 d(χ²=10.254,P=0.001)、应用广谱抗菌药物(χ²=13.888,P<0.01)、皮肤黏膜破损(χ²=5.923,P=0.015)方面差异有统计学意义。 结论: CTBI耐药率及病死率高,针对耐唑类热带念珠菌,推荐使用两性霉素B或棘白菌素+氟胞嘧啶联合治疗,降低治疗相关死亡风险。.

来源:Zhonghua Er Ke Za Zhi,查看原文。版权归原作者所有。

引用

  1. Yan L, Zheng MC, Ju XL, et al. [Clinical analysis of 14 cases with childhood acute lymphoblastic leukemia complicated with tropical candidemia]. Zhonghua Er Ke Za Zhi. 2020. PMID: 32987460. doi:10.3760/cma.j.cn112140-20200323-00298

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。